The IPO allotment process for Western Overseas Study Abroad Ltd. is expected to be finalised today, on December 9, 2025. The IPO opened for subscription on December 4, 2025, and closed yesterday on December 8, 2025. This is a fixed price issue of ₹10.07 crores, and the tentative listing date has been finalised for December 11, 2025.
Here’s how to check Western Overseas Study Abroad IPO Allotment Status on BSE SME and the registrar’s website.
Procedure to Check Western Overseas Study Abroad IPO Allotment Status Online On BSE
- Click here to visit the application status page.
- In Issue Type, “Equity”.
- In Issue Name, select “Western Overseas Study Abroad Ltd.”.
- Enter your “Application No.” or “PAN No.”
- Click on “I am not a robot”.
- Click “Submit”.
Procedure to Check Western Overseas Study Abroad IPO Allotment Status on Skyline Financial Services Pvt. Ltd. (Registrar to the issue)
- Click here to visit the Skyline Financial Services Pvt. Ltd website.
- In the Check Application Status section, first select the Company from the list.
- On the next page, enter the DPID/Client ID, the Application Number, or the Investor's PAN.
- Click on Search to view the IPO details on your screen.
Western Overseas Study Abroad Ltd. IPO Details
- Issue type: The Western Overseas Study Abroad Ltd. IPO is a fixed price issue of ₹10.07 crores. It comprises an entirely fresh issue of 0.18 crore shares aggregating to this amount.
- Listing: The IPO will list on the BSE SME.
- Issue price: ₹56 per share.
- Lot size: 2,000:
- Minimum investment amount:
- For individual investors (retail) - ₹2,24,000.00 (4,000 shares) based on the upper price
- For HNIs - 6,000 shares or 3 lots, aggregating to ₹3,36,000
- Book running lead manager: Sobhagya Capital Options Pvt. Ltd.
- Registrar: Skyline Financial Services Pvt. Ltd.
- Market Maker: Giriraj Stock Broking Pvt. Ltd.
Western Overseas Study Abroad Ltd. IPO Overall Subscription Status
The Western Overseas Study Abroad Ltd. IPO saw an overall subscription of 1.41 times as per the BSE data as of 08 December 2025, end of day.
The public issue was subscribed:
- 2.43 times by Retail Individual Investors (RIIs)
- 0.39 times by Non-Institutional Investors (NIIs)
- 1 time by the Market Maker
Explore other Upcoming IPOs on BSE and NSE.
Utilisation of Proceeds
The company plans to utilise the net proceeds from the fresh issue towards:
- ₹3.43 crores- financing advertisement expenditure towards enhancing the visibility and awareness of the brand
- ₹3.00 crores- financing software acquisition and installation
- ₹2 crores- repayment or payment of all/or a particular portion of outstanding borrowings availed by the company
- ₹0.74 crores- General corporate purposes
Check out newly Listed IPOs on BSE and NSE.
About Western Overseas Study Abroad Ltd
Founded in 2013, Western Overseas Study Abroad Ltd. is involved in offering educational and immigration advisory services, along with visa-related guidance. The company also provides language training (IELTS, TOEFL, CELPIP, PTE, LanguageCert, and Duolingo), in tandem with foreign language courses, consulting services, and workshops. It offers solutions to students from various states, such as Punjab, Chandigarh, Delhi, Haryana, and Madhya Pradesh. It also offers loan guidance, education consultancy, language training, scholarship assistance, career support, and visa services. It has 12 branches and 1 back-end office, with training classrooms and individual consultant desks.
Financially, the company reported:
- Higher revenues of 13% and growth in PAT (profit after tax) by 86% between the financial year ending with March 31, 2025 and March 31, 2024
- Assets of ₹13.87 crores by June 30, 2025, along with EBITDA of ₹0.87 crores and PAT of ₹0.54 crores for this period.
- Total income stood at ₹4.97 crores as of June 30, 2025, while the company had reserves and surplus of ₹2.86 crores by this period. Its net worth stood at ₹7.07 crores as of this date, while the total borrowings were ₹4.63 crores, as of June 30, 2025.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here